Epazz DeskFlex adds a vaccine management solution that tracks employee vaccination against COVID-19
Chicago, Illinois – (Newsfile Corp – November 10, 2020) – Epazz Inc. DeskFlex (OTC Pink: EPAZ), a leading provider of mission-critical cloud computing software solutions, announced today that DeskFlex’s vaccine management solution will help organizations plan and develop COVID-19 vaccination programs among its team members upon release
Pharmaceutical companies are working doubly to create a vaccine against the emerging corona virus 2019. One of the leading pharmaceutical companies has developed a vaccine with a promising result of 90% effectiveness according to the company’s clinical results. More than 43,538 volunteers participated and received two injections within 21 days apart. Of the 94 evaluable COVID-19 cases, the results revealed that more than 90% of the cases were successful in preventing coronavirus infection This result exceeded the FDA set a minimum efficacy of 50% This promising result will pave the way for mass vaccinations if the FDA approves the final stage of testing
DeskFlex Vaccine Management software will facilitate tracking and managing employee immunization against Coronavirus Allows employees to indicate vaccination history through the Health Records Management Service As the development of approved COVID-19 vaccines is on the way, company officials can monitor which team member completed the vaccination and which employees need Reminder to schedule and receive COVID-19 vaccine with DeskFlex Vaccine Management Solution
The Center for Disease Control and Prevention (CDC) and other collaborative health agencies began the Immunization Integration Program (IIP) four years ago after doctors found it difficult to track and improve adult vaccines. The program began The goal of the program was to help automate tasks related to immunization using Electronic health record and clinic software systems thus, by digitizing vaccination records and schedules, the program aims to increase vaccination rates among the adult population and secure these immunization records in cloud-based storage
DeskFlex room and office scheduling software solutions pride themselves on offering organizations a comprehensive suite of COVID-compliant software features The launch of DeskFlex Vaccine Management will enhance health and safety measures in the workplace
According to Shawn Basley, Ph.D., Chairman and CEO of Epazz, Inc, “We are optimistic that adding the Vaccine Management Program feature will secure the workplace and schools more against COVID-19 infection. When officials identify those who haven’t had the vaccine, they can Take the appropriate decision to protect the majority «
DeskFlex is a desk reservation solution and room reservation software useful for reserving conference rooms, meeting rooms, work spaces, offices, parking and office equipment. The DeskFlex conference room scheduling system helps office managers accommodate remote office worker time in the office, reducing rental and utility costs. Employees pre-book offices or claim desks on the spot Sets a Phone Key (PBX), so calls ring in « desk du jour » « DeskFlex includes floor maps for check-in, tagging and clicking, web browser, local kiosk, Outlook integration and conference room scheduling.
Epazz, Inc, is a leading cloud-based software company that specializes in providing custom cloud applications to the corporate world, higher education institutions, and the public sector. Epazz BoxesOS ™ v300 is a complete web-based software package for small and medium-sized businesses, Fortune 500 organizations, government agencies, and higher education institutions BoxesOS provides many web-based applications that you may need to purchase separately Other Epazz products are K9Sky com kennel software and applicant tracking system from Provitrac
This is a “safe harbor” statement under the Securities Litigation Reform Act 1995: Some of the statements in this press release are “forward-looking statements” within the meaning of the Securities Litigation Reform Act 1995. Forward-looking statements can generally be identified by using Forward-looking words such as “may,” “expect,” “intend,” “estimate,” “expect,” “believe,” “communicate,” (or deny) or similar terms such forward-looking statements are subject to risks, uncertainties, and other factors that may trigger Indicates that actual results differ materially from future results or those implicit in these forward-looking statements Investors caution that no forward-looking statement is a guarantee of future performance and that actual results may differ materially from those envisaged in such forward-looking statements. Ibaz. You do not assume any obligation and have no intention to update these forward-looking statements. Prepared by third parties that have not been paid for by Epazz, Inc. Investors are encouraged to review Epazz, Inc.’s public filings of SECgov and otcmarketscom, including its unaudited and unaudited financial statements and OTC market deposits, which contain general commercial information about the company’s operations and results. Operations and risks associated with the company and its operations
Here we go a week after the national election and we still don’t know the final results in a few states but the market has made some assumptions – it always does.
Exxon Mobil has prioritized maintaining dividends while oil prices remain low. Is Exxon a good buy?
Jim Kramer shares insights on stock discovery to buy, stimulus deals, and President-elect Joe Biden’s different approach to the Coronavirus
If you pull back this week, you might have missed the long-awaited rally in cheap stocks but there’s still an opportunity left in the S&P 500 and beyond
Is permanent rotation of stocks about to take hold? This is the question that investors are dealing with after the sharp difference between small-cap stocks and faltering periodicals that outperformed big-cap technology-related companies, amid evidence of progress toward a coronavirus vaccine.
Transportation-focused startup Elon Musk, The Boring Company, is recruiting engineering and operations jobs in Austin, Texas – an indication that the company is looking to start a new venture in the area What happened: The infrastructure-focused company hailed the geology of the city. Texas in a tweet – saying it provides « one of the best soils for tunneling – » as it announced, « Austin jobs are now available. » Austin jobs are now available https: // tco / imlQMDfprJ >> – The Boring Company (boringcompany) November 9, 2020 Half a dozen roles in Austin span from electrical engineer to employee accountant Why it matters: Musk’s Tesla Inc. (NASDAQ: TSLA) is building Gigafactory to manufacture Cybertruck and Semi as well as the Model 3 and Model Y in Austin The plant could employ up to 15,000 people, according to the Austin Business Journal in September, the carmaker was also looking to hire video game engineers and infotainment software developers in Austin There is no clarity about what If Boring is in talks with local officials about a tunneling project or if this future project is linked to Gigafactory Factory SEE ALSO: Elon Musk’s Boring launches new « Beat the Snail » challenge Image Courtesy: Steve Jurvetson via Flickr See more from Benzinga * click here To get deal options from Benzinga * Eli Lilly’s Antibody Treatment for COVID-19 Gets FDA Emergency Permission * Boeing 737 Max Jets May Be Groundless Next Week: (C) 2020 Report Benzin GA.com does not provide investment advice. All rights reserved.
Chinese electric vehicle manufacturer NIO Limited (NIO) may be one of the hottest stocks in an already overheated stock market in the past 52 weeks alone, NIO’s stock is up 2,138%, and according to Morgan’s analyst JR Nick Lai, NIO’s not over yet – that $ 44 stock might go up to the $ 46 level Now, we know what you’re thinking of $ 46 a share – isn’t that just a few dollars more than NIO’s $ 44 share costs today? Isn’t that some kind of colossal profit in the race after him? The answer is ‘yes’ to both questions, however, Lai still wants to explain why he thinks you should buy NIO stocks, so let’s let him go ahead and present his case (to see Lai’s track record, click here) even in the Chinese auto market where he granted government support Generous (which ran until 2022 by the way) investors are a case of « Tesla fever, » says Lai, and even in the electric car market, companies from all sectors are bidding for a « potential overrun » of valuations, NIO stocks will be « long-term winners in the space. » Premium electric vehicles, with a market share of about 30% by 2025 “Helping this will be a new electric sedan model (EC6) that will launch NIO for the first time in December, joining the company’s current offerings of two electric SUVs and an electric crossover car.” In addition, he argues Lai believes that NIO is more than just a car company that sells cars « directly » to customers as it is « a pioneer among Chinese electric car peers driving the transformation of the business model from a traditional car maker to a combination of an intelligent mobility provider and monetization opportunity » and yes, there is a lot of chatter for companies In that statement, but roughly what Lai says here is that he believes NIO has the ability not only to sell cars to consumers, and to raise money for those sales, NIO also offers « different types of content (like entertainment) » as well as services like battery replacement, both of which It may provide additional revenue beyond revenue from selling cars in the first place These potential “different types of content” may carry higher than average profit margins – in Lai’s view, high enough to raise the company’s gross margin from 8% in the second quarter. 2020 to up to 12% -13% in the third quarter 2020 is correct, even Lai doesn’t expect any of this to translate into actual (or even operating) net profits before 2023 at the earliest. But he seems to think that profits will eventually materialize and with projected revenues rising from $ 7 to $ 8 billion last year and may reach $ 65 billion by 2022 (the last year for which he gave an estimate), Lai believes the stock is at least worthy of its current valuation of around 77. Double the sales of last year – maybe a little more Is the rest of the street in agreement? As it turns out, the analyst consensus is more than just a mixed bag 6 buy ratings, 3 portfolios and 1 sale set in the past three months, giving the NIO a moderate buyout status however, with the $ 26 96 average price target, there are nearly 39% down from current levels (see NIO stock analysis at TipRanks) To find good stock trading ideas with attractive valuations, visit Best Stocks to Buy from TipRanks, a newly launched tool that unites all TipRanks stock insights Disclaimer: Opinions featured in this article They are only opinions of a distinguished analyst. The content is intended to be used for informational purposes only. It is very important to do your analysis before making any investment.
Growing pressure from investors around the world is forcing the multi-trillion dollar transportation industry to adapt or be left behind.
Dealers in India told Harley-Davidson Inc on Tuesday that they are exploring legal measures against the iconic US motorcycle brand after it has effectively exited the market as part of a broader restructuring plan Rishi Agarwal, the motorcycle company’s dealer, told reporters that a number of dealers They hired leading Indian law firm AZB & Partners to review their papers with Harley-Davidson and suggest if there is legal remedy.
Nikola CEO Mark Russell spoke with Yahoo Finance Live about the way forward for his company and discussions with General Motors
Today we discovered that not only did they cover their salaries, but that many of their choices were doubly blessed. Here’s why
Are marijuana stocks a good buy amid the coronavirus pandemic? The marijuana industry is getting a lot of hype, but hemp stocks have weak fundamentals and technologies.
Yes, the participation rate in Zoom Video increased during the Coronavirus crisis but after the pandemic, what are the expectations for Zoom share as Wall Street looks forward? Is ZM stock buy now before Zoomtopia?
Growth stocks dominated the first decade of the 21st century, and when 2020 began, many investors felt it was time for value stocks to take the lead. In theory, a bear market would be the ideal time for value stocks to outperform growth. , But from a year now, many valuable names have continued to underperform their growth-minded peers; Inexpensive energy companies, in particular, have continued to decline as oil prices fall combined with lower demand amid the pandemic The only financial stock on this list is $ 5 2 billion OneMain Holdings is a consumer credit and insurance company that is priced fairly conservatively. / p>
The good news for the pharmaceutical giant could be good news for other vaccine makers who have come a long way in the testing process
(Bloomberg) – two travel industry giants – Carnival Corp. and American Airlines Group Inc – are profiting from a coronavirus vaccine pool to sell shares Carnival, the world’s largest cruise company, has sold up to $ 1 5 billion in shares after its shares rose On Monday, people familiar with the matter said American Airlines had separately priced an offer of about $ 500 million in common stock at $ 13 a share The moves come at an appropriate moment: Investors in both companies are optimistic that a Covid-19 vaccine could boost their fortunes for Carnival. Monday’s gains are the largest one-day increase on record however, the stock is still down by about two-thirds this year – and the downward slide has resumed Tuesday In a file on Tuesday, Carnival said it will raise funds for corporate public purposes. The Miami-based company completed the sale of 67 lots 1 One million common shares under a similar program Cruise companies are trying to convince regulators and consumers that sailing is safe, but the industry may face an uphill battle until a vaccine becomes widely available Expect equity loosening Also weighing on stocks Tuesday, stocks tumbled 12% to $ 16 91 in New York trade American Airlines also fell on Tuesday, falling 53% to $ 12.50 It has fallen 56% this year separately, Norwegian Cruise Line Holdings Ltd CFO Mark Kimba told a conference call on Tuesday that the company would consider a potential capital increase « on an opportunity basis, » while adding that he had a « solid runway » of liquidity and was in no hurry and Kimba said potential moves could include raising money in the stock market to shore up their coffers. Amidst a halt in operations, cruise companies were already forced to sell equity stakes cheap and pay unusually high interest rates on new debt Last month, a conditional order from UQ. The Centers for Disease Control and Prevention has created a route for cruise lines to return to Yos Water but companies will first need to demonstrate that sailing is safe For more articles like this one, please visit us at Bloomberg comSubscribe now to stay on top with the most trusted business news source © 2020 Bloomberg The Else
In August a tanker named Otoman, No. 21, docked at the oil port of Jose on the coast of Venezuela in the Caribbean to load 182 million barrels of heavy crude, according to internal documents of the state oil company. The misidentification of Othmani is not a single mistake, according to documents The company reviewed by Reuters, shipping databases and company records, as well as interviews with Iranian state officials and four people close to the state oil company Petroleos de Venezuela SA (PDVSA) Sources close to PDVSA said that since the United States imposed sanctions on Venezuela in 2019, the state company and some shipping agencies have ignored protocols to verify the identity of the tanker.
Taiwanese processor chip maker for Apple Inc. and other customers plan to invest $ 3 billion to build the U-II manufacturing site amid US concerns about an over-reliance on Asia’s sources of high-tech components Taiwan Semiconductor Manufacturing Corporation, the world’s largest contract maker for semiconductors, said the board Its management on Tuesday approved a plan for the facility in Arizona. Yus officials are concerned that their country is relying too heavily on factories in Taiwan, South Korea and China for chips used in smartphones, medical equipment and other products.
Epazz Inc, Vaccine, Management
World News – Australia – Epazz DeskFlex will launch a vaccine management solution as part of its COVID compliance features
Related Title :
– Desk Scheduling Program Epazz DeskFlex Will Release Vaccine Management Solution As Part of COVID Compliance
– Epazz, Inc: Epazz DeskFlex Desk Scheduling Program will launch vaccine management solution as part of COVID
Donnez votre avis et abonnez-vous pour plus d’infos
Vidéo du jour: